RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL

Catalog number BNC402663-100

Price for BNC402663-100

Size / count 1x 100 µL

About this product

The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney. Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC402663-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Cadherin family member 12 (CDHF12) ; Cadherin related family member 16 (CDHR16) ; ELKS; HSCR1; Hydroxyaryl protein kinase; MEN2A; MEN2B; MTC1; Multiple endocrine neoplasia and medullary thyroid carcinoma 1; Oncogene RET; Proto-oncogene c-Ret; Proto-oncogene tyrosine-protein kinase receptor ret; PTC; RET; RET ELE1; RET51; RET9
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: RET
Gene ID: 5979
NCBI Gene ID: 350321
UniProt: P07949
Swiss Prot: P07949
Host: Mouse
Species Reactivity: Human
Reactivity: RET Proto-oncogene
Immunogen: Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)
Target Antigen: RET Proto-oncogene
Clonality: Monoclonal
Clone: RET/2663
Type: Primary
Source: Animal
Origin: Animal
Positive Control: Breast, Prostate or Colon Carcinoma.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 150 kDa (precursor) ; 170 kDa (Mature)
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG2b, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF640R

Frequently Asked Questions

What is the catalog number for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL?

The catalog number for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is BNC402663-100.

What sizes are available for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL?

RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL in stock?

RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL?

RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL?

Estimated delivery time for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL?

The safety data sheet for RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0296061270361e0ffdea/msds/bnc402663-100.pdf.

What is RET Proto-oncogene (RET/2663), CF640R conjugate, 0.1mg/mL used for?

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Can this product be used for co-immunoprecipitation (Co-IP)?

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.